Strategic Partnerships Capricorn Pharma’s specialty oral drug delivery platforms—KORTABS, Rapidmelt, Flashbeads, KORBEADS, and KORCAPS—create attractive co-development and licensing opportunities with larger pharmaceutical companies seeking differentiated formulations and faster path to market.

End-to-end CDMO With an integrated focus on innovation, development, commercialization and manufacturing, Capricorn Pharma offers end-to-end capabilities that appeal to biotech and pharma clients looking for a single partner to shorten development timelines and reduce program risk.

Patient-centric Solutions The patient-friendly nature of technologies like Rapidmelt and Flashbeads positions Capricorn Pharma to engage customers targeting pediatric or elderly populations who require easy-to-administer, fast-dissolving formulations.

US Footprint Located in Frederick, Maryland, the company can capitalize on a North American manufacturing footprint to support regional partners with closer supply chains, faster regulatory communications, and potentially shorter lead times.

Differentiated Value By highlighting its novel oral delivery platforms as a differentiator, Capricorn Pharma can pursue licensing, collaboration, or milestone-based deals with mid-market and large pharma looking to augment their portfolios with innovative delivery technologies.